Home/Pipeline/Robotic Biopsy System

Robotic Biopsy System

Tissue biopsy needle guidance

Research/ConceptActive

Key Facts

Indication
Tissue biopsy needle guidance
Phase
Research/Concept
Status
Active
Company

About Veebot

Veebot is a private, pre-revenue medical device company pioneering robotic needle insertion for vascular access and biopsy procedures. The company has developed a working prototype with demonstrated success in over 25 insertions and holds key intellectual property with multiple patents. Targeting the vast market of manual needle insertions, Veebot's solution promises greater accuracy, reduced pain, and the potential to expand care settings. Its success hinges on clinical validation, regulatory clearance, and achieving commercial scale in a competitive medtech landscape.

View full company profile

Therapeutic Areas